全文获取类型
收费全文 | 51418篇 |
免费 | 4446篇 |
国内免费 | 386篇 |
专业分类
耳鼻咽喉 | 819篇 |
儿科学 | 1073篇 |
妇产科学 | 989篇 |
基础医学 | 8081篇 |
口腔科学 | 896篇 |
临床医学 | 4873篇 |
内科学 | 10181篇 |
皮肤病学 | 1690篇 |
神经病学 | 4459篇 |
特种医学 | 2792篇 |
外科学 | 6180篇 |
综合类 | 565篇 |
一般理论 | 17篇 |
预防医学 | 3419篇 |
眼科学 | 1425篇 |
药学 | 4431篇 |
中国医学 | 423篇 |
肿瘤学 | 3937篇 |
出版年
2023年 | 229篇 |
2021年 | 1018篇 |
2020年 | 739篇 |
2019年 | 1139篇 |
2018年 | 1294篇 |
2017年 | 1026篇 |
2016年 | 1492篇 |
2015年 | 1951篇 |
2014年 | 2317篇 |
2013年 | 2777篇 |
2012年 | 3934篇 |
2011年 | 3818篇 |
2010年 | 2323篇 |
2009年 | 1938篇 |
2008年 | 2765篇 |
2007年 | 2785篇 |
2006年 | 2519篇 |
2005年 | 2395篇 |
2004年 | 2073篇 |
2003年 | 1866篇 |
2002年 | 1694篇 |
2001年 | 992篇 |
2000年 | 957篇 |
1999年 | 817篇 |
1998年 | 366篇 |
1997年 | 319篇 |
1996年 | 277篇 |
1995年 | 300篇 |
1994年 | 258篇 |
1993年 | 272篇 |
1992年 | 606篇 |
1991年 | 647篇 |
1990年 | 555篇 |
1989年 | 598篇 |
1988年 | 605篇 |
1987年 | 584篇 |
1986年 | 518篇 |
1985年 | 519篇 |
1984年 | 408篇 |
1983年 | 356篇 |
1982年 | 274篇 |
1981年 | 254篇 |
1980年 | 227篇 |
1979年 | 316篇 |
1978年 | 283篇 |
1977年 | 207篇 |
1976年 | 189篇 |
1974年 | 221篇 |
1973年 | 238篇 |
1972年 | 186篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Lee Hee Yun Hao Zhichao Choi Eun Young 《Journal of immigrant and minority health / Center for Minority Public Health》2022,24(4):996-1004
Journal of Immigrant and Minority Health - Little attention has been paid to online health information seeking (OHIS) among immigrants residing in rural areas. This study examines the intensity of... 相似文献
2.
Hyun Cheol Chung MD PhD Yoon-Koo Kang MD PhD Zhendong Chen MD Yuxian Bai MD Wan Zamaniah Wan Ishak MD Byoung Yong Shim MD Young Lee Park MD Dong-Hoe Koo MD PhD Jianwei Lu MD Jianming Xu MD Hong Jae Chon MD Li-Yuan Bai MD Shan Zeng MD Ying Yuan MD Yen-Yang Chen MD Kangsheng Gu MD Wen Yan Zhong PhD Shu Kuang MD Chie-Schin Shih MD Shu-Kui Qin MD PhD 《Cancer》2022,128(5):995-1003
3.
Sleep and Breathing - The presence of periodic limb movements during sleep (PLMS) varies among patients with obstructive sleep apnea (OSA) undergoing treatment with continuous positive airway... 相似文献
4.
So Young Jeon Oh Eun Kwon Jin Woo Jang Sang Yoon Kang Jin-Young Min Sung Wan Kim 《Auris, nasus, larynx》2021,48(5):1031-1034
Stickler syndrome is a genetic disorder of connective tissue. One of the major symptoms associated with this disorder is an oro-facial malformation, which may cause a submucous cleft or a complete cleft of the hard palate. A 32-year-old man diagnosed with Stickler syndrome and a submucosal cleft palate (SMCP) visited our hospital with a chief complaint of excessive daytime sleepiness. The patient was diagnosed with severe obstructive sleep apnea (OSA), and administration of a polysomnography test revealed an apnea-hypopnea index (AHI) of 30.9 events/hour (h). Auto-titrating continuous positive airway pressure was initiated to control the OSA symptoms and subsequently the patient showed some improvement. However, due to continuous velopharyngeal insufficiency symptoms, intravelar veloplasty was performed. Three months after surgery, the AHI had decreased to 12.4 events/h. Recent studies have described a greater risk for OSA in individuals with cleft palate, than in the general population. The present case demonstrates surgical success in a patient with OSA and SMCP, suggesting that palatal surgery may be considered an optional surgical treatment for OSA patients with SMCP. 相似文献
5.
D. R. Frei R. Beasley D. Campbell A. Forbes K. Leslie D. Mackle C. Martin A. Merry M. R. Moore P. S. Myles L. Ruawai-Hamilton T. G. Short P. J. Young 《Anaesthesia》2023,78(10):1272-1284
International recommendations encourage liberal administration of oxygen to patients having surgery under general anaesthesia, ostensibly to reduce surgical site infection. However, the optimal oxygen regimen to minimise postoperative complications and enhance recovery from surgery remains uncertain. The hospital operating theatre randomised oxygen (HOT-ROX) trial is a multicentre, patient- and assessor-blinded, parallel-group, randomised clinical trial designed to assess the effect of a restricted, standard care, or liberal peri-operative oxygen therapy regimen on days alive and at home after surgery in adults undergoing prolonged non-cardiac surgery under general anaesthesia. Here, we report the findings of the internal vanguard feasibility phase of the trial undertaken in four large metropolitan hospitals in Australia and New Zealand that included the first 210 patients of a planned overall 2640 trial sample, with eight pre-specified endpoints evaluating protocol implementation and safety. We screened a total of 956 participants between 1 September 2019 and 26 January 2021, with data from 210 participants included in the analysis. Median (IQR [range]) time-weighted average intra-operative FiO2 was 0.30 (0.26–0.35 [0.20–0.59]) and 0.47 (0.44–0.51 [0.37–0.68]) for restricted and standard care, respectively (mean difference (95%CI) 0.17 (0.14–0.20), p < 0.001). Median time-weighted average intra-operative FiO2 was 0.83 (0.80–0.85 [0.70–0.91]) for liberal oxygen therapy (mean difference (95%CI) compared with standard care 0.36 (0.33–0.39), p < 0.001). All feasibility endpoints were met. There were no significant patient adverse events. These data support the feasibility of proceeding with the HOT-ROX trial without major protocol modifications. 相似文献
6.
7.
8.
Seulbi Lee Hyesook Park Soontae Kim Eun-Kyung Lee Jiyoung Lee Young Sun Hong Eunhee Ha 《International journal of hygiene and environmental health》2019,222(3):533-540
Background
It has been reported that particulate matter (PM) is associated with cardiovascular diseases (CVD) while metabolic syndrome is also an important risk factor for CVD. However, few studies have investigated the epidemiological association between PM and metabolic syndrome.Objective
To investigate the association between one-year exposure to PM with an aerodynamic diameter <2.5?μm (PM2.5) and the risk of metabolic syndrome in Korean adults without CVD.Methods
Exposure to PM2.5 was assessed using a Community Multiscale Air Quality (CMAQ) model. Metabolic syndrome was defined by National Cholesterol Education Program Adult Treatment Panel III. Andersen and Gill model with time-varying covariates, considering recurrent events, was used to investigate the association between one-year average PM2.5 and the risk of incident metabolic syndrome in 119,998 adults from the national health screening cohort provided by Korea National Health Insurance from 2009 to 2013.Results
Higher risk of metabolic syndrome, waist-based obesity, hypertension, hypertriglyceridemia, low HDL cholesterol, and hyperglycemia were significantly associated with a 10-μg/m3 increase in PM2.5 [adjusted hazard ratio (HR): 1.070, 1.510, 1.499, 1.468, 1.627 and 1.380, respectively]. In addition, the risk of metabolic syndrome associated with PM2.5 exposure was significant in the consistently obese group (obese at baseline and endpoint).Conclusion
Exposure to one-year average PM2.5 is associated with an increased risk of metabolic syndrome and its components in adults without CVD. These associations are particularly prominent in the consistently obese group (obese at baseline and endpoint). Our findings indicate that PM2.5 affects the onset of MS and its components which may lead to increase the risk of CVD. 相似文献9.
Sun‐Mi Yoo Cheol‐Jung Lee Han Chang Kang Hye Suk Lee Joo Young Lee Kwang Dong Kim Dae Joon Kim Hyun‐Jung An Yong‐Yeon Cho 《Molecular carcinogenesis》2019,58(7):1221-1233
Mammalian target of rapamycin (mTOR) has a pivotal role in carcinogenesis and cancer cell proliferation in diverse human cancers. In this study, we observed that epimagnolin, a natural compound abundantly found in Shin‐Yi, suppressed cell proliferation by inhibition of epidermal growth factor (EGF)‐induced G1/S cell‐cycle phase transition in JB6 Cl41 cells. Interestingly, epimagnolin suppressed EGF‐induced Akt phosphorylation strongly at Ser473 and weakly at Thr308 without alteration of phosphorylation of MAPK/ERK kinases (MEKs), extracellular signal‐regulated kinase (ERKs), and RSK1, resulting in abrogation of the phosphorylation of GSK3β at Ser9 and p70S6K at Thr389. Moreover, we found that epimagnolin suppressed c‐Jun phosphorylation at Ser63/73, resulting in the inhibition of activator protein 1 (AP‐1) transactivation activity. Computational docking indicated that epimagnolin targeted an active pocket of the mTOR kinase domain by forming three hydrogen bonds and three hydrophobic interactions. The prediction was confirmed by using in vitro kinase and adenosine triphosphate‐bead competition assays. The inhibition of mTOR kinase activity resulted in the suppression of anchorage‐independent cell transformation. Importantly, epimagnolin efficiently suppressed cell proliferation and anchorage‐independent colony growth of H1650 rather than H460 lung cancer cells with dependency of total and phosphorylated protein levels of mTOR and Akt. Inhibitory signaling of epimagnolin on cell proliferation of lung cancer cells was observed mainly in mTOR‐Akt‐p70S6K and mTOR‐Akt‐GSK3β‐AP‐1, which was similar to that shown in JB6 Cl41 cells. Taken together, our results indicate that epimagnolin potentiates as chemopreventive or therapeutic agents by direct active pocket targeting of mTOR kinase, resulting in sensitizing cancer cells harboring enhanced phosphorylation of the mTORC2‐Akt‐p70S6k signaling pathway. 相似文献
10.
Ho Seok Chung Eu Chang Hwang Myung Soo Kim Seong Hyeon Yu Seung Il Jung Taek Won Kang Chan Choi Seock Hwan Choi Tae Gyun Kwon Joon Hwa Noh Myung Ki Kim Won Jin Cho Sung Gu Kang Seok Ho Kang Jun Cheon Ill Young Seo Hong Chung Hong Sup Kim Dongdeuk Kwon 《Clinical genitourinary cancer》2019,17(3):e394-e407
PurposeTo determine the prognostic effect of upper tract urothelial carcinoma (UTUC) with variant histology (VH) after radical nephroureterectomy (RNU).Patients and MethodsThe data of 1173 patients who received RNU for UTUC without neoadjuvant chemotherapy in 11 institutions between 2002 and 2016 were retrospectively reviewed. A matched propensity score analysis was performed. Clinicopathologic variables, recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) were compared between patients with pure UTUC and patients with UTUC and VH. Univariate and multivariate Cox proportional regression models were used to determine the independent variables associated with oncologic outcomes.ResultsUTUC with VH was observed in 93 patients (7.9%). After propensity score matching, UTUC with VH showed no difference in clinicopathologic features compared to pure UTUC; however, it was associated with shorter RFS, CSS, and OS (log rank, P = .011, P = .002, P = .006, respectively). Additionally, the multivariate analysis revealed that VH was independently associated with a poor RFS [hazard ratio (HR) = 1.92; 95% confidence interval (CI), 1.27-2.89; P = .002], CSS (HR = 4.47; 95% CI, 1.99-10.1; P = .001), and OS (HR = 3.00; 95% CI, 1.55-5.78; P = .001). However, the Kaplan-Meier method revealed that differences in RFS, CSS, and OS were not significant in patients who received adjuvant chemotherapy (log rank, P = .562, P = .060, P = .153, respectively).ConclusionUTUC with VH was independently associated with poor oncologic outcomes in patients with UTUC after RNU. Although patients with UTUC and VH had a poor prognosis compared to patients with pure UTUC, adjuvant chemotherapy would be helpful in improving the survival rates of these patients. 相似文献